preparation contained 1-2 µM LFn, which corresponded to 50-100 LFn molecules per liposome. (Gibco Life Technologies) was used for transfection. Selected blasticidine-resistant clones were 8 screened for TEM8 expression by Western blotting using c-myc monoclonal antibody 9 (Invitrogen). A clone with the highest TEM8 expression was designated CHO-TEM8 and used 10 for this work. CHO-K1 and CHO-TEM8 cells were grown in F-12 medium, RAW 264.7 cells 11 were grown in DMEM. Both media included 10 % FBS (HyClone), 2 mM L-glutamine and 12
antibiotics. Cells were maintained at 37 o C, 5% CO 2 . 13
Microscopy -Cells were incubated in complete culture medium containing 8 nM PA, with or 14 without AmPrβCD (10 or 100 µM), for 15 (250 mM  2 sucrose, 20 mM HEPES pH 7.4, 1% NP-40, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 25 µg/ml 3 antitripsin, 25 µg/ml aprotinin). Cell lysates were clarified by centrifugation (10,000 x g for 2 4 min) and supplemented with 2 mM DTT to preserve caspase enzymatic activity. Total protein in 5 cytosolic fractions was determined by Bio-Rad protein assay (Bio-Rad, Hercules, CA). Aliquots 6 containing 40 µg of cytosolic protein were analyzed in a final volume of 100 µl of caspase 7 activity buffer (0.1 M HEPES pH 7.4, 2 mM DTT, 0.1% NP-40, 1% sucrose) containing 50 µM 8 of caspase substrate. Reaction mixtures were incubated for 1 hour at 37 o C, and flourescence was 9 measured at λ ex = 400 nm and λ em = 505 nm. 10
11

RESULTS
12
To develop LFn-based fluorescent tracers, we fused LFn to a 15-aa long cysteine-containing 13
Cys-tag for site-specific modification (4) and His-tag for purification (Fig. 1A, inset) . Given the 14 crucial importance of the N-terminal portion of LFn for binding to PA (45), we have chosen C-15 terminus for tag fusion. Wild type LFn does not contain cysteine residues, and the only reactive 16 thiol group in LFn-Cys fusion protein is provided by a cysteine in position 4 of C-terminal Cys-17 tag. To obtain LFn-Al, LFn-Cys was modified with a thiol-reactive fluorescent dye AlexaFluor-18 594 maleimide and purified by gel-filtration. RP-HPLC analysis confirmed a 1:1 ratio of protein 19 to dye in the conjugate, LFn-Al (Fig. 1A) . To obtain LFn-Lip, LFn-Cys was lipidated with a 20 thiol-reactive PEGylated phospholipid, mPEG-DSPE maleimide, yielding ~50% of modified 21 protein within minutes (Fig. 1B) . For insertion of lipidated LFn-Cys into liposomal membrane, 22 the lipidation reaction mixture was added to pre-formed liposomes loaded with HPTS, a 23
A C C E P T E D
on October 16, 2017 by guest http://aac.asm.org/ Downloaded from membrane-impenetrable fluorescent dye, and incubated for 16 hrs at 37 o C followed by 1 purification of the resulting LFn-Lip from free LFn-Cys by gel-filtration on Sepharose 4B (Fig.  2   1B) . 3
The specificity of binding to PA was established for both LFn-based tracers by competition 4 with full-length LF for binding to cellular PA/ANTXR complexes (assay described in 4). In this 5 assay, varying amounts of either tracer or unmodified LFn-Cys are added to RAW 264.7 cells 6 exposed to LeTx formed by combination of LF and PA. LeTx is highly toxic for RAW 264.7 7 cells, and therefore the ability of non-toxic LFn to compete with full-length LF for binding to 8 cell-associated PA is readily detected by the number of viable RAW 264.7 cells after a 3-h 9 exposure to LeTx. We found that under selected conditions, unmodified LFn-Cys rescued RAW 10 264.7 cells with IC 50 of 3.5+0.4 nM, which is close to activity of LFn (IC 50 ~ 3 nM) reported 11 earlier (4). Notably, both LFn-Al and LFn-Lip tracers displayed similar activity in this assay with 12 IC 50 of 4.3+0.3 nM (Fig. 1C) , indicating that site-specific C-terminal attachment of either a 13 highly charged fluorescent dye or a bulky liposome did not dramatically affect binding of Cys to cell-associated PA. 15 To monitor PA-mediated LFn-Al internalization, we initially tested two ANTXR positive cell 16 lines: RAW 264.7 mouse monocytes expressing CMG-2 (8), and CHO-K1 hamster ovary 17 fibroblasts expressing an unidentified ANTXR (12, 30). Receptor-mediated endocytosis was 18 observed by fluorescent microscopy of cells incubated with LFn-Al in the presence of PA, while 19 cells incubated with LFn-Al alone served as control for non-specific uptake. We found that 20 punctate Alexa-594 fluorescence was readily detectable in RAW cells in the presence, but not in 21 the absence of PA, indicating PA/CMG2 mediated endocytosis of the tracer ( Fig. 2A) (Fig.  4 2A), and was used for further studies. It should be noted that a prolonged incubation (1 h) with 5
LFn-Al at 37 o C was necessary to reach detectable levels of the fluorescent probe in both cell 6 types, while no cell-associated fluorescence was detected after a shorter (15-min) incubation 7 (data not shown). both cell types in the presence of 10 µM and 100 µM AmPrβCD (Fig 2A for 100 µM  12 AmPrβCD), indicating that either binding or uptake was inhibited by the drug. Given relatively 13 low affinity of LFn to PA even at room temperature (Kd~1 nM) (19), the lack of membrane-14 In similar experiments performed on RAW 264.7 cells, binding of LFn-Al to RAW 264.7 1 cells at 4 o C was not detectable (data not shown). Although it was, most likely, due to the low 2 level of the endogenous CMG2, we could not rule out a possibility that AmPrβCD might directly 3 inhibit binding of this tracer to PA/CMG2. We therefore used the protection assay described 4 above ( Fig. 1C) to compare the effects of AmPrβCD alone, or in combination with LFn-Al, on 5 CMG2-mediated toxicity of LeTx. We reasoned that if AmPrβCD does not affect PA-mediated 6
LFn-Al binding, a combination of these two compounds might be more effective than each one 7 alone. In our standard LeTx protection assay (0.2 nM LF, 2 nM PA, 3-h exposure), AmPrβCD 8 alone protected RAW 264.7 cells at micromolar concentrations with IC 50 of ~7 µM (Fig. 3A) , 9
while LFn-Al was active in this assay, with IC 50 of 4 nM ( analyze whether drugs given simultaneously are additive, synergistic, or antagonistic (9). 12 AmPrβCD was mixed with LFn-Al at the corresponding working concentrations resulting in a 13 molar ratio of 2,000:1, serially diluted in complete culture medium and added to cells exposed to 14
LeTx. We found that the combination of two compounds was significantly more effective in this 15 assay than each compound alone, with IC 50 values of ~1.2 µM for AmPrβCD and ~0.6 nM for 16
LFn-Al. Fractional IC 50 values (ratio of IC 50 for a drug in combination to IC 50 for a drug alone) 17 were determined as 0.17, for each compound ( Since our data indicated that AmPrβCD acted outside of the cell, it was conceivable that, due 22 to its high positive charge, AmPrβCD could bind to the cell surface and non-specifically affect 23 endocytosis of many different cellular receptors. We therefore tested if AmPrβCD could inhibit 1 endosytosis of an anthrax-unrelated ligand/receptor complex. For these experiments we used 2 SLT-VEGF, a chimeric toxin comprising the full-length Shiga-like toxin (SLT) subunit A fused 3 to vascular endothelial growth factor (VEGF) described in (3). SLT-VEGF is internalized via 4 VEGF receptor-mediated endocytosis and is highly toxic for 293/KDR cells expressing VEGF 5 receptor VEGFR-2 at nanomolar levels. AmPrβCD was serially diluted in complete culture 6 medium containing 1 nM SLT-VEGF and added to 293/KDR cells at the same concentration 7 range that was used for protection of RAW 264.7 cells from LeTx ( Fig 3A) . As a positive control 8 for cell rescue we used VEGF that protects 293/KDR cells from toxicity of SLT-VEGF by 9 competing for VEGFR-2 binding (4, 5, 7). We found that AmPrβCD did not protect 293/KDR 10 cells from SLT-VEGF-induced toxicity (Fig. 3B) , indicating that its effects were limited to 11 PA/ANTXR complexes. 12
To establish if AmPrβCD inhibition of PA-mediated LF uptake depends on the presence of 13 LF in the complex, we used a novel PA cytotoxicity assay. While characterizing CHO-TEM8 14 cells, we found that PA alone was cytotoxic to these cells in a dose-dependent manner (Fig. 4A) . 15
Parental CHO-K1 cells were not sensitive to PA in the same concentration range (Fig. 4A) , 16 indicating a causative role of high-level TEM8 expression for PA-induced toxicity. A similar 17 PA-induced/LF-independent toxicity has been recently reported for RAW 264.7 cells engineered 18 to overexpress TEM8 (37). We found that PA-induced toxicity was completely blocked by 5 µM 19 AmPrβCD (Fig. 4A) . Using fluorogenic assays with pan-and specific caspase substrates, we also 20 found that AmPrβCD inhibited PA-induced apoptosis in CHO-TEM8 cells by blocking the 21 overall caspase activity, and more specifically initiator caspase-2 and executioner caspases -3 22 and -7 (Fig. 4B) . 23
on October 16, 2017 by guest http://aac.asm.org/ Downloaded from PA-induced toxicity observed on TEM8 overexpressing RAW 264.7 cells was tentatively 1 attributed to a large number of pores formed by internalized PA in endosomal compartments 2 (37). If this suggested mechanism is correct, LF and its derivatives sould also rescue CHO-3 TEM8 cells from PA-induced toxicity by blocking PA membrane channel, as it was recently 4 described for PA channels reconstituted in artificial lipid bilayer membranes (35). Indeed, we 5
found that LFn and both LFn-targeted fluorescent tracers successfully rescued CHO-TEM8 cells 6 in a similar dose-dependent manner (Fig. 4C , for LFn-Lip). As expected, untargeted HPTS-7 loaded liposomes did not prevent cell death in this assay (Fig. 4C) . 8
Judging by the ability to protect RAW 264.7 cells from LeTx ( Fig. 1C) and CHO-TEM8 9 cells from PA-induced toxicity (Fig. 4C) β-cyclodextrins demonstrated structure-activity relationships within this class of compounds 7 (24), supporting the hypothesis of specific interactions between β-cyclodextrins and PA. Based 8 on the ability of AmPrβCD to inhibit ion currents through PA pore reconstituted into a lipid 9 bilayer, it was suggested that this compound might inhibit translocation of LF or EF inside the 10 cell through PA pore formed in endosomes at mildly acidic conditions (24, 25). However, we 11 report here that AmPrβCD selectively inhibits receptor-mediated endocytosis of PA/LFn-Al 12 complex by either of two anthrax receptors, TEM8 and CMG2. Furthermore, using a new assay 13 for TEM8-mediated LF-independent PA cytotoxicity, we found that AmPrβCD action does not 14 even require binding of LF to PA/TEM8 complex. Taken together, these data indicate that 15 AmPrβCD inhibits LF toxicity by acting in a PA-specific manner on the cell surface rather than 16 inside the cell. On the other hand, judging by inhibition of PA-induced/LF-independent toxicity 17 by LFn-Al and LFn-Lip, PA can be also inhibited inside the cells. 
